-
Celgene Corporation v. Dr. Reddy's Laboratories, Ltd. et al DC
- 2:18-cv-06378
- D.N.J.
- Judge: Susan D. Wigenton
+1
- Filed: 04/12/2018
- Closed: 09/17/2020
- Latest Docket Entry: 09/17/2020
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
5
Accused
Products
5
Patents-in-Suit
1,156
Days in
Litigation
-
Celgene Corporation v. Dr. Reddy's Laboratories, Ltd. et al DC
- 2:18-cv-06378
- D.N.J.
- Judge: Susan D. Wigenton
+1
- Filed: 04/12/2018
- Closed: 09/17/2020
- Latest Docket Entry: 09/17/2020
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Dr. Reddy's Lab., Inc.
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,315,720 B1 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,561,977 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,755,784 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 8,315,886 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 8,626,531 B2 | All Asserted Claims |
Infringement
Entry 67
|
Dr. Reddy's Laboratories Ltd.
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,315,720 B1 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,561,977 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 6,755,784 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 8,315,886 B2 | All Asserted Claims |
Infringement
Entry 67
|
| Lenalidomide capsules 10 mgLenalidomide capsules 15 mgLenalidomide capsules 20 mgLenalidomide capsules 2.5 mgLenalidomide capsules 5 mg | US 8,626,531 B2 | All Asserted Claims |
Infringement
Entry 67
|
